Panalgo announces new Amsterdam office

After landing a new contract with the European Medicines Agency (EMA), the leading healthcare analytics company Panalgo is moving to the Amsterdam Area. The firm’s healthcare analytics software IHD helps businesses simplify the analytics process by removing complex programming to turn data into insights more easily. Panalgo is based in Boston, Massachusetts, and rebranded from Boston Health Economics (BHE) around six months ago. It says that establishing an office in the Amsterdam Area, the home of the EMA, will help it to provide expert support to the regulator for the roll-out and management of the new software.

To choose its new analytics software, the EMA conducted a rigorous evaluation of several platforms, with Panalgo’s IHD receiving the highest score. “We are excited to partner with the EMA to support its mission of ensuring the efficacy and safety of medical products throughout the EU,” said Joseph Menzin, Panalgo's CEO. “Our company is strongly aligned with the EMA’s public health goals, for which timely evidence-based insights are of particular importance, especially during this Covid-19 pandemic.”

Why the Amsterdam Area’s life science and health sector is thriving

The EMA was forced to move out of the UK due to Brexit and selected the Netherlands from 19 EU-member states during a secret ballot in 2017. It officially moved into its Zuidas office building, which was constructed in just 18 months, at the end of 2019. The EMA’s move helped cement the Amsterdam Area as a world-leading life sciences and health hub. Though no official figures have yet been released, the leading regulatory agency’s presence was predicted to attract hundreds of new companies to the region.

The Amsterdam Area has internationally renowned universities, academic hospitals and research institutions. Its life sciences and health industry thrives on cooperation and the proximity of businesses and academic institutions, which creates a unique synergy few other locations can offer. The region is also becoming a specialist in medical data science. In fact, Amsterdam has been the base for a number of new developments in the field in recent times, including a ‘world first’ project for intensive care units across the Netherlands to share their data to improve patient care.

Read more business news from around Amsterdam.